Tumormarker pp 95-104 | Cite as

Carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) for prognosis and monitoring of patients with lung canger

  • Giuseppe De Angelis
  • A. Cipri
  • C. Maccone
  • F. Pau
  • F. Pigorini
  • F. Salvati
Conference paper

Abstract

Lung cancer is an aggressive type of tumor in which, despite removal of most of the tumor by surgery or the reduction of carcinoma to low levels by chemotherapy or radiotherapy (especially small cell), there is still a high rate of recurrence of progressive disease within 12 years. Therefore, it is relatively easy to design trials to evaluate the importance of markers for prognosis, as an aid in determining therapy, or for following patients for early detection of recurrent disease. In this type of tumor a wide variety of hormonal and non hormonal markers has been studied. Among the non hormonal ones the tumor associated antigens (TAA) have been demonstrated to be useful for praticai clinical purposes; especially CEA in conjunction with TPA, although these tests are not highly tumor specific, was found to be quite useful in the management of lung cancer (3, 6) and was observed to give higher reliability than other tumor tests used together (7). The objective in the planning of this study was to clarify the interpretation and application of these tests to monitoring of the patients undergoing chemotherapy.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Joint Committee for Cancer Staging and End Results Reporting (1973) Clinical Staging System for Carcinoma of the Lung. ChicagoGoogle Scholar
  2. 2.
    De Angelis G, Cruciani A R, Cipri A, Flore F, Pau F, Munno R, Salvati F, Antilli A (1983) Two markers in non small cell lung cancer ( NSCLC ): Carcinoembryonic Antigen (CEA) and Tissue Polypeptide Antigen (TPA). Prognostic value. Cancer Detect Prey 6: 587Google Scholar
  3. 3.
    Flore F, Cipri A, De Angelis G, Munno R, Pau F, Pigorini F (1985): Correlation of Tissue Polypeptide Antigen (TPA) and Carcinoembryonic Antigen (CEA) levels with prognosis and clinical features in lung cancer during treatment. J Nucl, Med Allied Sci 29: 78-80Google Scholar
  4. 4.
    Hide D C (1981): Staging procedures and prognostic factors in small cell carcinoma of the lung. In: Greco F A et al (eds) Small cell lung cancer. Grune and Stratton New YorkGoogle Scholar
  5. 5.
    Lokich J J (1982) Plasma CEA levels in small cell lung cancer Correlation with stage, distribution of metastases, and survival. Cancer 50: 2154 - 2156PubMedCrossRefGoogle Scholar
  6. 6.
    Lüthgens M, Schlegel G: (1985) Tissue Polypeptide Antigen and Carcinoembryonic Antigen in the clinical follow-up of lung cancer patients. Congr Int: Marker tumorali: utilita+2 diagnostica e valore prognostico. NaplesGoogle Scholar
  7. 7.
    Schlegel G, Lüthgens M, Eklund G, Björklund B (1981) Correlation between activity in breast cancer and CEA, TPA and eighteen common laboratory procedures and the improvement by combined use of CEA and TPA. Tumor Diagnostik, 2: 6-1Google Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1987

Authors and Affiliations

  • Giuseppe De Angelis
    • 1
    • 2
  • A. Cipri
    • 1
  • C. Maccone
    • 1
  • F. Pau
    • 1
  • F. Pigorini
    • 1
  • F. Salvati
    • 1
  1. 1.C. Forlanini Chest HospitalRomeItaly
  2. 2.RomeItaly

Personalised recommendations